Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.
Drug Development, Preclinical Drug Development
Steven L. Wagner, Ph.D.
Rudy Tanzi, Ph.D.
Can (Martin) Zhang, Changning Wang, | 2023
Tamir Ben-Hur, Herve Bercovier, | 2023
Liisa Galea, Annie Ciernia, | 2022
Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021
Kevin Rynearson, | 2021
Jeffrey Savas, | 2021
Raja Bhattacharyya, Rudy Tanzi, | 2021
Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Rudy Tanzi, William Eimer, | 2020